|
68
|
239
|
5zguA |
Crystal structure of ndm-1 at ph7.0 (hepes) with 2 molecules per asymmetric unit |
|
78
|
229
|
5zgxA |
Crystal structure of ndm-1 at ph7.5 (succinate) with 1 molecule per asymmetric unit |
|
78
|
229
|
5zgyA |
Crystal structure of ndm-1 at ph7.5 (bis-tris) with 1 molecule per asymmetric unit |
|
71
|
239
|
5zgtA |
Crystal structure of ndm-1 at ph7.5 (hepes) with 2 molecules per asymmetric unit |
|
75
|
229
|
5zgfA |
Crystal structure of ndm-1 q123g mutant |
|
85
|
241
|
5zgeA |
Crystal structure of ndm-1 at ph5.5 (bis-tris) in complex with hydrolyzed ampicillin |
|
70
|
240
|
5zh1A |
Crystal structure of ndm-1 at ph7.5 (imidazole) with 2 molecules per asymmetric unit |
|
82
|
241
|
5zgpA |
Crystal structure of ndm-1 at ph6.2 (bis-tris) in complex with hydrolyzed ampicillin |
|
77
|
228
|
5zgiA |
Crystal structure of ndm-1 at ph6.5 (succinate) with 1 molecule per asymmetric unit |
|
67
|
221
|
5y5bA |
Crystal structure of imp-1 metallo-beta-lactamase |
|
71
|
231
|
5yd7A |
Crystal structure of vim-2 metallo-beta-lactamase |
|
111
|
359
|
5xhrA |
Crystal structure of p99 beta-lactamase in complex with a penicillin derivative mpc-1 |
|
105
|
277
|
5vpqA |
Crystal structure of beta-lactamase from burkholderia phymatum |
|
73
|
237
|
5bohA |
Crystal structure of oxa-58 with the substrate-binding cleft in a closed state |
|
64
|
231
|
5acuA |
Vim-2-nat, discovery of novel inhibitor scaffolds against the metallo- beta-lactamase vim-2 by spr based fragment screening |
|
92
|
260
|
5a92A |
15k x-ray structure with cefotaxime: exploring the mechanism of beta- lactam ring protonation in the class a beta-lactamase acylation mechanism using neutron and x-ray crystallography |
|
91
|
260
|
5a90A |
100k neutron ligand free: exploring the mechanism of beta-lactam ring protonation in the class a beta-lactamase acylation mechanism using neutron and x-ray crystallography |
|
95
|
260
|
5a93A |
293k joint x-ray neutron with cefotaxime: exploring the mechanism of beta-lactam ring protonation in the class a beta-lactamase acylation mechanism using neutron and x-ray crystallography |
|
80
|
236
|
5a5zA |
Approved drugs containing thiols as inhibitors of metallo-beta- lactamases: strategy to combat multidrug-resistant bacteria |
|
85
|
264
|
5aebA |
Crystal structure of the class b3 di-zinc metallo-beta-lactamase lra- 12 from an alaskan soil metagenome. |
|
71
|
230
|
5a87A |
Crystal structure of the metallo-beta-lactamase vim-5 |
|
72
|
229
|
4znbA |
Metallo-beta-lactamase (c181s mutant) |
|
72
|
242
|
4y0tA |
Crystal structure of apo form of oxa-58, a carbapenem hydrolyzing class d beta-lactamase from acinetobacter baumanii (p21, 4mol/asu) |
|
74
|
231
|
4exyA |
Crystal structure of ndm-1 bound to ethylene glycol |
|
99
|
270
|
4ev4A |
Crystal structure of serratia fonticola carbapenemase sfc-1 e166a mutant with the acylenzyme intermediate of meropenem |
|
85
|
241
|
4ey2A |
Crystal structure of ndm-1 bound to hydrolyzed methicillin |
|
81
|
241
|
4eybA |
Crystal structure of ndm-1 bound to hydrolyzed oxacillin |
|
89
|
265
|
4q8iA |
Crystal structure of beta-lactamase from m.tuberculosis covalently complexed with tebipenem |
|
76
|
231
|
4eylA |
Crystal structure of ndm-1 bound to hydrolyzed meropenem |
|
79
|
245
|
4f94A |
Structure of the class d beta-lactamase oxa-24 k84d in acyl-enzyme complex with oxacillin |
|
99
|
270
|
4euzA |
Crystal structure of serratia fonticola carbapenemase sfc-1 s70a-meropenem complex |
|
77
|
239
|
4exsA |
Crystal structure of ndm-1 bound to l-captopril |
|
83
|
241
|
4eyfA |
Crystal structure of ndm-1 bound to hydrolyzed benzylpenicillin |
|
123
|
358
|
4e3iA |
Crystal structure of ampc beta-lactamase in complex with a designed 3-carboxyl benzyl sulfonamide boronic acid inhibitor |
|
80
|
265
|
4eblA |
Blac e166a faropenem acyl-intermediate complex |
|
80
|
265
|
4ebpA |
Blac e166a cefotaxime acyl-intermediate complex |
|
124
|
358
|
4e3mA |
Crystal structure of ampc beta-lactamase in complex with a 2-chloro-4-tetrazolyl benzene sulfonamide boronic acid inhibitor |
|
98
|
335
|
4e6wA |
Clbp in complex with 3-aminophenyl boronic acid |
|
79
|
265
|
4ebnA |
Blac amoxicillin acyl-intermediate complex |
|
125
|
358
|
4e3lA |
Crystal structure of ampc beta-lactamase in complex with a 3-chloro-4-tetrazolyl benzene sulfonamide boronic acid inhibitor |
|
89
|
336
|
4e6xA |
Clbp in complex boron-based inhibitor |
|
101
|
271
|
4eqiA |
Crystal structure of serratia fonticola carbapenemase sfc-1 |
|
123
|
358
|
4e3oA |
Crystal structure of ampc beta-lactamase in complex with a small chloromethyl sulfonamide boronic acid inhibitor |
|
115
|
358
|
4e3jA |
Crystal structure of ampc beta-lactamase in complex with a designed 4-tetrazolyl benzene sulfonamide boronic acid inhibitor |
|
208
|
637
|
4dxbA |
2.29a structure of the engineered mbp tem-1 fusion protein rg13 in complex with zinc, p1 space group |
|
202
|
637
|
4dxcA |
Crystal structure of the engineered mbp tem-1 fusion protein rg13, c2 space group |
|
125
|
358
|
4e3nA |
Crystal structure of ampc beta-lactamase in complex with a 2-trifluoromethyl-4-tetrazolyl benzene sulfonamide boronic acid inhibitor |
|
125
|
358
|
4e3kA |
Crystal structure of ampc beta-lactamase in complex with a designed 4-tetrazolyl pyridine sulfonamide boronic acid inhibitor |
|
90
|
280
|
4d2oA |
Crystal structure of the class a extended-spectrum beta-lactamase per- 2 |
|
93
|
263
|
4de1A |
Ctx-m-9 class a beta-lactamase complexed with compound 18 |
